MedKooCat#:200078
Name:AC480HCl
CAS#:873837-23-1(HClsalt);714971-09-2(freebase).
ChemicalFormula:C27H28ClFN8O3
ExactMass:566.2
MolecularWeight:567.02
ElementalAnalysis:C,57.19;H,4.98;Cl,6.25;F,3.35;N,19.76;O,8.46
Synonym:AC480;AC-480;AC480HCl;AC480hydrochloride;BMS599626;BMS-599626;BMS599626;BMS599626HCl;BMS599626hydrochloride.
IUPAC/ChemicalName:(S)-morpholin-3-ylmethyl(4-((1-(3-fluorobenzyl)-1H-indazol-5-yl)amino)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)carbamatehydrochloride
InChiKey:COUSSRGSHIJMMN-FTBISJDPSA-N
InChiCode:InChI=1S/C27H27FN8O3.ClH/c1-17-23(34-27(37)39-15-22-14-38-8-7-29-22)13-36-25(17)26(30-16-32-36)33-21-5-6-24-19(10-21)11-31-35(24)12-18-3-2-4-20(28)9-18;/h2-6,9-11,13,16,22,29H,7-8,12,14-15H2,1H3,(H,34,37)(H,30,32,33);1H/t22-;/m0./s1
SMILESCode:O=C(OC[C@H]1NCCOC1)NC2=CN3N=CN=C(NC4=CC5=C(N(CC6=CC=CC(F)=C6)N=C5)C=C4)C3=C2C.[H]Cl
1:SoriaJC,CortesJ,MassardC,ArmandJP,DeAndreisD,RopertS,LopezE,CatteauA,JamesJ,MarierJF,BeliveauM,MartellRE,BaselgaJ.PhaseIsafety,pharmacokineticandpharmacodynamictrialofBMS-599626(AC480),anoralpan-HERreceptortyrosinekinaseinhibitor,inpatientswithadvancedsolidtumors.AnnOncol.2012Feb;23(2):463-71.doi:10.1093/annonc/mdr137.Epub2011May16.PubMedPMID:21576284.
2:TorresMA,RajuU,MolkentineD,RiestererO,MilasL,AngKK.AC480,formerlyBMS-599626,apanHerinhibitor,enhancesrADIosensitivityandradioresponseofheadandnecksquamouscellcarcinomacellsinvitroandinvivo.InvestNewDrugs.2011Aug;29(4):554-61.doi:10.1007/s10637-010-9389-3.Epub2010Feb2.PubMedPMID:20119866.
3:GavaiAV,FinkBE,FairfaxDJ,MartinGS,RossiterLM,HolstCL,KimSH,LeavittKJ,MastalerzH,HanWC,NorrisD,GoyalB,SwaminathanS,PatelB,MathurA,VyasDM,TokarskiJS,YuC,OppenheimerS,ZhangH,MaratheP,FargnoliJ,LeeFY,WongTW,ViteGD.Discoveryandpreclinicalevaluationof[4-[[1-(3-fluorophenyl)methyl]-1H-indazol-5-ylamino]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamicacid,(3S)-3-morpholinylmethylester(BMS-599626),aselectiveandorallyefficaciousinhibitorofhumanepidermalgrowthfactorreceptor1and2kinases.JMedChem.2009Nov12;52(21):6527-30.doi:10.1021/jm9010065.PubMedPMID:19821562.
4:HaluskaP,CarboniJM,TenEyckC,AttarRM,HouX,YuC,SagarM,WongTW,GottardisMM,ErlichmanC.HERreceptorsignalingconfersresistancetotheinsulin-likegrowthfactor-Ireceptorinhibitor,BMS-536924.MolCancerTher.2008Sep;7(9):2589-98.doi:10.1158/1535-7163.MCT-08-0493.Epub2008Sep2.PubMedPMID:18765823;PubMedCentralPMCID:PMC2614316.
5:WongTW,LeeFY,YuC,LuoFR,OppenheimerS,ZhangH,SmyklaRA,MastalerzH,FinkBE,HuntJT,GavaiAV,ViteGD.PreclinicalantitumoractivityofBMS-599626,apan-HERkinaseinhibitorthatinhibitsHER1/HER2homodimerandheterodimersignaling.ClinCancerRes.2006Oct15;12(20Pt1):6186-93.PubMedPMID:17062696.
6:AlbanellJ,GascónP.SmallmoleculeswithEGFR-TKinhibitoractivity.CurrDrugTargets.2005May;6(3):259-74.Review.PubMedPMID:15857287.